{"id":33599,"date":"2025-04-22T16:44:30","date_gmt":"2025-04-22T14:44:30","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=33599"},"modified":"2025-05-15T11:57:35","modified_gmt":"2025-05-15T09:57:35","slug":"an-investors-nightmare-is-missing-out-on-a-successful-product-empowering-biotech-leaders-navigating-finance-event-a-recap","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/an-investors-nightmare-is-missing-out-on-a-successful-product-empowering-biotech-leaders-navigating-finance-event-a-recap\/","title":{"rendered":"\u201cAn investors nightmare is missing out on a successful product!\u201d – Empowering Biotech Leaders: Navigating Finance Event, A Recap\u00a0"},"content":{"rendered":"\n

Last week, hollandbio had the pleasure of welcoming 50 biotech founders and C-level executives to our first-ever exclusive financing event: Empowering Biotech Leaders: Navigating Finance<\/a>. The event was organized in response to requests from our members, who \u2013 despite working in diverse fields within biotech \u2013 often face similar challenges: high-risk ventures, substantial funding needs, and long timelines to market. Ultimately, everyone is looking for the right funding to bring their innovation to the people who need it most.\u00a0<\/p>\n\n\n\n

In her opening speech, hollandbio\u2019s Wieteke Wouters pointed to the growing Valley of Death, where more and more, the winner takes it all. To help our members beat the odds, we invited three seasoned biotech leaders to share their hard-earned lessons: Sjoerd van Gorp (Citryll), Paul van der Horst (Agomab), and biotech veteran Andr\u00e9 Hoekema. <\/p>\n\n\n\n

Their engaging presentations covered key topics like how to close a deal, create FOMO among investors, and build long-term value. Some standout takeaways: <\/p>\n\n\n\n